Barlogie, Bart <br/><br/>
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Feb 2006 
 - 929-36 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2005.04.5807  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bone Marrow Transplantation<br/>Carmustine--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Clinical Protocols<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Interferons--administration & dosage<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Prednisone--administration & dosage<br/>Prospective Studies<br/>Radiotherapy, Adjuvant<br/>Salvage Therapy--methods<br/>Survival Analysis<br/>Transplantation, Autologous<br/>Transplantation, Homologous<br/>Treatment Failure<br/>Treatment Outcome<br/>United States<br/>Vincristine--administration & dosage<br/>Whole-Body Irradiation